Sickle Cell Disease
Sickle cell disease (SCD) is the most prevalent genetic disease in the World Health Organization’s (WHO) African Region. It is estimated more than 300,000 babies are born with severe forms of hemoglobinopathies worldwide each year. While 75 percent of all patients with SCD live in Sub-Saharan Africa, Nigeria alone accounts for more than 100,000 new births every year.
In accordance with the Nigeria Global Health Initiative, CDC is working with several partners to plan and implement programs to address the public health burden of SCD in Nigeria:
- “Preventing Infectious Disease Deaths in African Children with Sickle Cell Disease”
Partners: Association of Public Health Laboratories, Michigan State University, National Hospital (Abuja)
- “Improving Hemoglobinopathy Prevention and Management Efforts through the Development and Evaluation of a Global Hemoglobinopathy Needs Assessment Tool”
Partners: Guys and St. Thomas Hospital (London, UK), Katsina State Government, Sickle Cell Cohort Research, SCORE (Nigeria)
- “Assessing an Association between Lead Poisoning and Sickle Cell Disease”
Partners: USAID, National Center on Environmental Health, Healthy Homes and Lead Poisoning Prevention Branch
Visit CDC’s Sickle Cell Disease Web site for more information about these activities.
- Page last reviewed: December 6, 2012
- Page last updated: December 6, 2012
- Content source:
Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.